Cargando…

Changes of Tumor Markers in Patients with Lung Cancer after Immunotherapy and Their Link with Inflammation in the Body

PURPOSE: To figure out tumor markers changes in lung cancer (LC) patients after immunotherapy and their link with inflammation in the body. METHODS: From May 2017 to January 2021, taking 97 LC patients with elevated Programmed Cell Death Protein 1 and Programmed Cell Death Protein-ligand 1 was as th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, LiWei, Cai, YuanChun, Tao, XiaoLan, Huang, Jing, Han, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325577/ https://www.ncbi.nlm.nih.gov/pubmed/35903437 http://dx.doi.org/10.1155/2022/7781686

Ejemplares similares

Retracted: Changes of Tumor Markers in Patients with Lung Cancer after Immunotherapy and Their Link with Inflammation in the Body
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Elevated tumor markers for monitoring tumor response to immunotherapy
por: Yang, Yi, et al.
Publicado: (2022)

Editorial: Tumor microenvironment, inflammation, and resistance to immunotherapies
por: Decock, Julie, et al.
Publicado: (2023)

Photoimmunotherapy: A New Paradigm in Solid Tumor Immunotherapy
por: Peng, Zheng, et al.
Publicado: (2022)

Frequency changes in HLA‐I alleles: A marker to guide immunotherapy in lung adenocarcinoma patients and its relationship with tumor mutational burden and PD‐L1 expression
por: Wu, Xuanpeng, et al.
Publicado: (2023)

Microglia in pediatric brain tumors: The missing link to successful immunotherapy
por: du Chatinier, Aimée, et al.
Publicado: (2023)

Beyond PD-L1 Markers for Lung Cancer Immunotherapy
por: Wojas-Krawczyk, Kamila, et al.
Publicado: (2019)

Cancer-Associated Glycosphingolipids as Tumor Markers and Targets for Cancer Immunotherapy
por: Groux-Degroote, Sophie, et al.
Publicado: (2021)

Baseline serum tumor markers predict the survival of patients with advanced non-small cell lung cancer receiving first-line immunotherapy: a multicenter retrospective study
por: Huang, Jian, et al.
Publicado: (2023)

Targeting Natural Killer Cells for Tumor Immunotherapy
por: Zhang, Cai, et al.
Publicado: (2020)

Dynamic monitoring of serum tumor markers as prognostic factors in patients with advanced non-small-cell lung cancer treated with first-line immunotherapy: a multicenter retrospective study
por: Yang, Xiongwen, et al.
Publicado: (2023)

LATPS, a novel prognostic signature based on tumor microenvironment of lung adenocarcinoma to better predict survival and immunotherapy response
por: Huang, Jihong, et al.
Publicado: (2022)

Trends and advances in tumor immunology and lung cancer immunotherapy
por: Aldarouish, Mohanad, et al.
Publicado: (2016)

Identification of Age-Associated Transcriptomic Changes Linked to Immunotherapy Response in Primary Melanoma
por: El-Helbawy, Nehal Farid, et al.
Publicado: (2022)

Changes in lung cancer-related serum tumor markers in patients with chronic kidney disease and determination of upper reference limit
por: Miao, Qiang, et al.
Publicado: (2022)

The Combination of Stereotactic Body Radiation Therapy and Immunotherapy in Primary Liver Tumors
por: Kreidieh, Malek, et al.
Publicado: (2019)

Inflammation Markers and FEF(25-75): A Relevant Link in Children With Asthma
por: Tosca, Maria Angela, et al.
Publicado: (2016)

Plasma Markers of Inflammation Linked to Clinical Progression and Decline During Preclinical AD
por: Gross, Alden L., et al.
Publicado: (2019)

Study on the Risk Factors of Pulmonary Infection after Laparoscopic Surgery and Analysis of the Detection Results of Drug-Resistant Bacteria
por: Zhai, Tingting, et al.
Publicado: (2022)

Liquid biopsy for lung cancer immunotherapy
por: Cai, Liang-Liang, et al.
Publicado: (2019)

Hypothalamic-pituitary-derived melanocortin axis links to myelopoiesis and immunotherapy
por: Zhang, Chao, et al.
Publicado: (2023)

Cavitation and fatal hemoptysis after immunotherapy for advanced lung adenocarcinoma: A case report
por: Wang, Ruijuan, et al.
Publicado: (2020)

Inflammatory Markers in Cancer Immunotherapy
por: Ravindranathan, Deepak, et al.
Publicado: (2021)

Lipid metabolism and tumor immunotherapy
por: Wang, Yue, et al.
Publicado: (2023)

Immunotherapy, Inflammation and Colorectal Cancer
por: Lichtenstern, Charles Robert, et al.
Publicado: (2020)

Changes of Tumor Markers in Patients with Breast Cancer during Postoperative Adjuvant Chemotherapy
por: Zhang, Yan, et al.
Publicado: (2022)

Body composition as a modulator of response to immunotherapy in lung cancer: time to deal with it
por: Trestini, I., et al.
Publicado: (2021)

Depressive symptoms predict longitudinal changes of chronic inflammation at the transition to adulthood
por: Zhai, Shuang, et al.
Publicado: (2023)

Identification of an Exosome-Related Signature for Predicting Prognosis, Immunotherapy Efficacy, and Tumor Microenvironment in Lung Adenocarcinoma
por: Lin, Tao, et al.
Publicado: (2022)

Single-cell insights into the dynamic tumor microenvironment changes during immunotherapy of non-small cell lung cancer
por: Prazanowska, Karolina Hanna, et al.
Publicado: (2023)

Impact of inflammation and immunotherapy in renal cell carcinoma
por: Shi, Jian, et al.
Publicado: (2020)

Lung cancer in never smokers: Tumor immunology and challenges for immunotherapy
por: de Alencar, Viviane Teixeira L., et al.
Publicado: (2022)

PM and Elevated Inflammation Markers: More Support for Air Pollution–Heart Disease Link
por: Weinhold, Bob
Publicado: (2007)

Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers
por: Aragón-Herrera, Alana, et al.
Publicado: (2022)

Efficacy of autoantibodies combined with tumor markers in the detection of lung cancer
por: Mu, Yinyu, et al.
Publicado: (2022)

Lung Function After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer, Changes and Predictive Markers
por: Berg, Janna, et al.
Publicado: (2021)

Changes in Inflammatory Markers in Bacterial- and Nifedipine-Induced Gingival Inflammation
por: George, Anitha, et al.
Publicado: (2015)

Linking Adiposity to Interstitial Lung Disease: The Role of the Dysfunctional Adipocyte and Inflammation
por: Macklin, Michael, et al.
Publicado: (2023)

Predicting response to immunotherapy in gastric cancer via assessing perineural invasion-mediated inflammation in tumor microenvironment
por: Li, Xunjun, et al.
Publicado: (2023)

Prior Lung Inflammation Impacts on Body Distribution of Gold Nanoparticles
por: Hussain, Salik, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ha65llg7gf45bjomeqlos9hd7t